According to the results of pathway analysis, mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 MAPK, may also play a crucial role in regulating diabetes and inflammation through the MAPK signaling pathway. This evidence concerns the gene MAPK1 and diabetes mellitus.